Henry Ford Health Systems

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Asthma1 trial
• Myasthenia gravis1 trial
• Type 1 diabetes1 trial
• Type 2 diabetes1 trial

Phase

• Phase 21 trial

Status

• Recruiting2 trials
• Active, not recruiting1 trial

Lead sponsor

• argenx1 trial
• Insulet Corporation1 trial
• University of Wisconsin, Madison1 trial

Running trials

• Recruiting

  Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System

  NCT07579702· Insulet Corporation· Source

  Contact: Lydia Oehring

• Recruiting

  ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

  NCT07284420· Phase 2· argenx· Source

  Contact: Kavita Grover, MD

• Active, not recruiting

  Childhood Allergy and the Neonatal Environment

  NCT04215783· University of Wisconsin, Madison· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Myasthenia gravis1 recruiting
• Type 1 diabetes1 recruiting
• Type 2 diabetes1 recruiting